Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22789511 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA
Condition: Hepatitis B
Interventions: Biological: HBVaxPRO® 5 µg / 0.5 mL;   Biological: Engerix B® 10 µg / 0.5 mL

Indicates status has not been verified in more than two years